| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | Aug 18, 2025 | Sale | $453.27 | 1,396 | 632,759 | 24,076 | Aug 19, 2025, 05:26 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | Feb 28, 2025 | Sale | $241.69 | 496 | 119,878 | 12,854 | Mar 03, 2025, 04:30 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | Feb 14, 2025 | Sale | $255.21 | 663 | 169,204 | 14,839 | Feb 18, 2025, 04:47 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | Feb 18, 2025 | Sale | $251.56 | 1,440 | 362,243 | 13,235 | Feb 18, 2025, 04:47 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | Nov 27, 2024 | Sale | $252.29 | 1,531 | 386,261 | 14,202 | Nov 27, 2024, 05:20 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | Nov 26, 2024 | Sale | $250.98 | 1,469 | 368,686 | 15,855 | Nov 27, 2024, 05:20 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | Aug 12, 2024 | Option/RSU Exercise | $89.09 | 20,725 | 1,846,429 | 34,906 | Aug 14, 2024, 04:12 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | Aug 12, 2024 | Sale | $270.99 | 22,025 | 5,968,516 | 33,485 | Aug 14, 2024, 04:12 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | Jun 25, 2024 | Sale | $230.99 | 1,198 | 276,731 | 15,334 | Jun 26, 2024, 04:26 PM |